Existing investors include Invigo Softwares and Prof Mohamed Rela, a liver transplant surgeon. The fresh investment will accelerate expansion and commercialisation of Episcreen Liver, a methylation-based liquid biopsy test for early liver cancer detection.
Co-founded in 2021 by Dr Srikar Raman and K Sreedurgalakshmi, Tvaster is into molecular diagnostics and precision oncology through epigenetic screening technologies.
…